The looming rash of herpes zoster and the challenge of adult immunization

Annals of Internal Medicine

Volumn 152, Issue 9, 2010, Pages 609-611

  Donahue, James G ^a   Belongia, Edward A ^a  

^a MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; OPIATE; VARICELLA ZOSTER VACCINE;

ADULT; ANTIVIRAL THERAPY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HEALTH CARE COST; HEALTH CARE UTILIZATION; HERPES ZOSTER; HUMAN; IMMUNIZATION; INFLUENZA VACCINATION; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RASH; REIMBURSEMENT; TOPICAL ANESTHESIA; UNSPECIFIED SIDE EFFECT; AGED; ECONOMICS; FEE; MIDDLE AGED; NOTE;

ADULT; AGED; FEES, PHARMACEUTICAL; HERPES ZOSTER; HERPES ZOSTER VACCINE; HUMANS; MIDDLE AGED; NEURALGIA, POSTHERPETIC;

EID: 77952532556     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-152-9-201005040-00011     Document Type: Editorial

References (18)

1. Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82:1341-9. [PMID: 17976353]
2. Centers for Disease Control and Prevention. Shingles Disease - Questions and Answers. Centers for Disease Control and Prevention. Accessed at www.cdc.gov/vaccines/vpd-vac/shingles/dis-faqs.htm on 9 February 2010.
3. Administration on Aging. Aging Statistics. Washington, DC: Department of Health and Human Services; 2010.
4. Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, et al. Recommendations for the management of herpes zoster. Clin Infect Dis. 2007;44 Suppl 1:S1-26. [PMID: 17143845]
5. Harpaz R, Ortega-Sanchez IR, Seward JF. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57:1-30; quiz CE2-4. [PMID: 18528318]
6. Lu PJ, Euler GL, Jumaan AO, Harpaz R. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors. Vaccine. 2009;27:882-7. [PMID: 19071175]
7. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. Shingles Prevention Study Group. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352:2271-84. [PMID: 15930418]
8. Simberkoff MS, Arbeit RD, Johnson GR, Oxman MN, Boardman KD, Williams HM, et al. Safety of herpes zoster vaccine in the Shingles Prevention Study. A randomized trial. Ann Intern Med. 2010:152:545-54.
9. Hurley LP, Lindley MC, Harpaz R, Stokley S, Daley MF, Crane LA, et al. Barriers to the use of herpes zoster vaccine. Ann Intern Med. 2010:152:555-60.
10. Schiller JS, Euler GL. Vaccination coverage estimates from the National Health Interview Survey: United States, 2008. July 2009. Centers for Disease Control and Prevention, Atlanta, Georgia. Accessed at www.cdc.gov/nchs/data/ hestat/vaccine-coverage.pdf on 9 February 2010.
11. Centers for Disease Control and Prevention (CDC). Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations - United States, 1996. MMWR Morb Mortal Wkly Rep. 1999;48:886-90. [PMID: 10550040]
12. Hinman AR, Orenstein WA. Adult immunization: what can we learn from the childhood immunization program? [Editorial]. Clin Infect Dis. 2007;44:1532-5. [PMID: 17516394]
13. Orenstein WA, Mootrey GT, Pazol K, Hinman AR. Financing immunization of adults in the United States. Clin Pharmacol Ther. 2007;82:764-8. [PMID: 17971821]
14. Levi J, Schaffner W, Cimons M, Guidos R, Segal LM. Adult Immunization: Shots to Save Lives. Washington, DC: Trust for America's Health; 2010.
15. American College of Physicians, Infectious Diseases Society of America. ACP-IDSA Joint Statement Regarding Adult Vaccination by Physicians. Arlington, VA: Infectious Diseases Society of America; 2008.
16. Infectious Diseases Society of America. IDSA Issues Policy Blueprint to Strengthen Adult and Adolescent Immunization. Accessed at www.idsociety.org/ adultimmunization.htm on 22 March 2010.
17. Immunization Work Group of the National and Global Public Health Committee of the Infectious Diseases Society of America. Actions to strengthen adult and adolescent immunization coverage in the United States: policy principles of the Infectious Diseases Society of America. Clin Infect Dis. 2007;44:e104-8. [PMID: 17516388]
18. Gilderman LI, Lawless JF, Nolen TM, Sterling T, Rutledge RZ, Fernsler DA, et al. Zostavax Protocol 010 Study Group. A double-blind, randomized, controlled, multicenter safety and immunogenicity study of a refrigerator-stable formulation of Zostavax. Clin Vaccine Immunol. 2008;15:314-9. [PMID: 18077611]